Biography

Dr. Soegianto Ali completed his medical degree at Universitas Indonesia in 1990. He pursued a Master’s degree at Katholieke Universiteit Leuven in 2000 and earned his Doctorate from Rijksuniversiteit Leiden in 2006. With expertise in Genetics (Host and Pathogen) and Immunology, Dr. Soegianto focuses his research on neurology and COVID-19 detection. As an educator, Dr. Soegianto teaches courses in Bioinformatics, Cellular & Molecular Biology of Aging, Biostatistics & Epidemiology, as well as several subjects in Pharmacogenomics and Hematology. He also plays a key role in enhancing students' understanding of Medical Education, Immunology, and Pathology Concepts. In his research, Dr. Soegianto has contributed significantly to understanding and managing neurological complications associated with COVID-19. His major publication, "Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications," explores the role of citicoline in treating cognitive and neurological issues in COVID-19 patients. Additionally, in "Increasing SARS-CoV-2 Clinical Testing Capacity in Indonesia with QuickSpit™," he discusses how QuickSpit™ technology can improve COVID-19 clinical testing capacity in Indonesia. Dr. Soegianto also investigated the use of saliva as a sample for SARS-CoV-2 detection and proposed a saliva pooling method to increase laboratory testing capacity. His recent study, "Interferon Gamma Release Assay Post BCG Among Newborns and Family Members Living in a Crowded Area in Jakarta, Indonesia," examines the immune response to the BCG vaccine. With a dedication to enhancing public health capacity, Dr. Soegianto continues to contribute to relevant and applicable research in Indonesia.

Education

Dr. Soegianto Ali completed his medical degree at Universitas Indonesia in 1990. He then pursued a Master's degree at Katholieke Universiteit Leuven in 2000 and earned his Doctorate from Rijksuniversiteit Leiden in 2006.

Expertise

Dr. Soegianto has expertise in Genetics (Host and Pathogen) and Immunology, particularly related to infectious diseases. His knowledge and experience in these fields enable the development of a deeper understanding of the interaction between genetics and immune responses in the context of disease.

Teaching

As an educator, Dr. Soegianto teaches a variety of courses, including Bioinformatics, Cellular & Molecular Biology of Aging, and Biostatistics & Epidemiology. He also instructs in Pharmacogenomics-Pharmacogenetics, Genetics I and II, and Hematology. Dr. Soegianto plays a crucial role in teaching Basic Biomedical Science across six levels of courses and helps students develop a deeper understanding of Medical Education, Immunology, and Pathology Concepts (1 and 2). Additionally, he provides instruction in Research Methodology, Advanced Microbiology, and Fundamental Medical Knowledge, and teaches about growth, development, and natural aging, the Cardiovascular System, as well as Biomedical Techniques I and II. With his commitment to delivering quality education, Dr. Soegianto continues to contribute to shaping a new generation of professionals in the fields of medicine and health.

Recent Publications

Dr. Soegianto Ali M.Med. Sc. is a health expert with a significant research focus in neurology and COVID-19 detection. His research contributes to the understanding and management of neurological complications related to COVID-19 and efforts to enhance clinical testing capacity in Indonesia.

One of his key publications, "Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications," explores the role of citicoline in addressing cognitive and neurological issues arising in COVID-19 patients. This study provides insights into potential therapies that could help restore neurological functions impacted by the virus.

In "Increasing SARS-CoV-2 Clinical Testing Capacity in Indonesia with QuickSpit™," Dr. Soegianto discusses how QuickSpit™ technology can enhance COVID-19 clinical testing capacity in Indonesia, an important step in speeding up the detection and management of the pandemic in the country.

Another study, "Wide Application of Minimally Processed Saliva on Multiple RT-qPCR Kits for SARS-CoV-2 Detection in Indonesia," highlights innovations in using saliva as a sample for detecting SARS-CoV-2. This approach simplifies testing, making it more accessible and efficient.

Dr. Soegianto also explores the technique of saliva pooling in "Accelerating the Laboratory Testing Capacity through Saliva Pooling Prior to Direct RT-qPCR for SARS-CoV-2 Detection," proposing a method that increases laboratory testing capacity without sacrificing accuracy.

In his latest publication, "Interferon Gamma Release Assay Post BCG Among Newborns and Family Members Living in a Crowded Area in Jakarta, Indonesia," Dr. Soegianto examines the immune response to the BCG vaccine in newborns and family members living in densely populated areas. This research is important for understanding vaccine efficacy in different demographic contexts.

Committed to enhancing public health capacity and understanding the impacts of COVID-19, Dr. Soegianto continues to contribute to relevant and practical research in Indonesia.